ShenW.BresslerR.: Clinical Pharmacology of Oral Antidiabetic Agents (First of Two Parts). N. Engl. J. Med.296: 493–497, 1977.
2.
LamerJ.HaynesR. G.: Insulin and Oral Hypoglycemic Drugs; Glucagon, The Pharmacologic Basis of Therapeutics, Fifth Ed., GoodmanL. S.GilmanA. (Eds.), New York, Macmillan, pp. 1521, 1975.
3.
ShawR. A.BeaserS. B.: The Insulins and Oral Antidiabetic Agents: Drills' Pharmacology in Medicine, Fourth Ed., DipalmaJ. R. (Ed.), McGraw Hill, New York, p. 151, 1971.
4.
BrothertonP. M.GrievesonP.McMartinC.: A Study of the Metabolic Fate of Chlorpropamide in Man, Clin. Pharmacol. Ther.10: 505–514, 1969.
5.
TaylorJ. A.: Pharmacokinetics and Biotransformation of Chlorpropamide in Man, Clin. Pharmacol. Ther.13: 710–718, 1973.
6.
PetitpierreB.PerrinL.RudhardtM.HerreraA.FabreJ.: Behavior of Chlorpropamide in Renal Insufficiency and Under the Effect of Associated Drug Therapy, Int. J. Clin. Pharmacol.6: 120–124, 1972.
7.
KristensenM.HansenJ. M.: Accumulation of Chlorpropamide Caused by Dicoumarol, Acta. Med. Scand.183: 83–86, 1968.
8.
PetitpierreB.FabreJ.: Chlorpropamide and Chloramphenicol, Lancet1: 789, 1970.